Oncologists Market Report 2026

Oncologists Market Overview

• Oncologists market size has reached to $20.21 billion in 2025 • Expected to grow to $25.07 billion in 2030 at a compound annual growth rate (CAGR) of 4.4% • Growth Driver: Growing Prevalence Of Cancer Drives The Oncologist Market • Market Trend: Revolutionize Cancer Care With AI-precision Oncology Centers for Personalized Treatment And Enhanced Outcomes. • North America was the largest region in 2025.

What Is Covered Under Oncologists Market?

Oncologists refer to a type of healthcare practitioner who is specialized in the diagnosis and treatment of cancer. Oncologists evaluate the patient, diagnose the cancer, and recommend treatments. They are employed in the treatment and care of cancer patients. The main cancer diagnostics and treatment of oncologists are cancer diagnostics and cancer treatment. Cancer diagnostics refers to testing procedures that confirm the presence of cancer and identify the tumor type. The indications such as lungs cancer, colorectal cancer, breast cancer, liver cancer, bladder cancer, head and neck cancer, prostate cancer with the end use included hospitals, diagnostic laboratories, diagnostic imaging centers, specialty clinics, academia and others.

What Is The Oncologists Market Growth Forecast?

The oncologists market size is expected to see steady growth in the next few years. It will grow to $25.07 billion in 2030 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to growth in personalized and targeted cancer therapies, adoption of digital oncology management solutions, technological innovations in immunotherapy and targeted therapy, expansion of oncology centers in emerging markets, increasing use of genomics and molecular diagnostics for treatment planning. Major trends in the forecast period include rising adoption of digital oncology platforms for patient management, increasing integration of ai and machine learning in cancer diagnosis, growing implementation of precision medicine and genomic profiling for personalized cancer therapy, rising automation in chemotherapy preparation and drug delivery, increasing iot-enabled monitoring of oncology equipment and patient data.

What Is The Driver Of The Oncologists Market?

The growing prevalence of cancer is expected to propel the oncologists market going forward. Cancer refers to a disease in which a few body cells grow uncontrollably and spread to other parts. The prevalence of cancer refers to the number of new cancer cases that arise in a specified population in a given period of time. Oncologists refer to healthcare practitioners who are specialized in the diagnosis and treatment of cancer. They are involved in examining the patient, diagnosing the cancer, and identifying treatment options. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the growing prevalence of cancer is driving the oncologists industry.

Key Players In The Global Oncologists Market

Major companies operating in the oncologists market are Abramson Cancer Center, MD Anderson Cancer Center of the University of Texas, Lilavati Hospital & Research Centre, Mount Elizabeth Hospital, Mount Miriam Cancer Hospital, Charité - Universitätsmedizin Berlin, General Electric Healthcare, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., Amgen Inc., Takeda Pharmaceuticals USA Inc., Becton Dickinson and Company, Cook Medical LLC, Terumo Corporation, AngioDynamics Inc., Thermo Fisher Scientific Inc., Illumina Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Eli Lilly and Company, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Incyte Corporation, Seattle Genetics Inc.

Global Oncologists Market Trends and Insights

Major companies operating in the oncologists market are focused on introducing AI-precision oncology centers to enhance personalized cancer treatment, improve diagnostic accuracy, and optimize treatment plans based on individual patient data and tumor characteristics. AI-precision oncology centers refer to specialized medical facilities that utilize artificial intelligence (AI) and machine learning technologies to provide highly personalized cancer care. For instance, in January 2024, Apollo Cancer Centre, an India-based hospital, launched Apollo Cancer Centre. The center will assist oncologists, patients, and caregivers in achieving the best possible outcomes within a defined timeframe by leveraging the vast potential of AI technology. The POC utilizes AI technologies to provide precise diagnoses and real-time insights into patient conditions. This capability allows for timely interventions and better management of cancer cases. The centre conducts comprehensive cancer risk assessments, helping to identify patients who may benefit from targeted therapies or immunotherapy as part of their treatment plans.

What Are Latest Mergers And Acquisitions In The Oncologists Market?

In July 2024, Mumbai Oncocare (MOC) Cancer Care & Research Centre, an India-based hospital and physicians clinics, that provides oncology care, merged with Hemato Oncology Clinic for an undisclosed amount. With this merger, Mumbai Oncocare aims to expand its portfolio by incorporating Hemato Oncology's expertise in providing a total of 40 medical oncologists and hematologists. Hemato Oncology Clinic is an India-based Hospital that offers advanced oncology care.

What Defines the Oncologists Market?

The oncologists market includes revenues earned by entities by providing diagnoses and treats cancer, radiation oncologists and surgical oncologists. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oncologists Market Report 2026?

The oncologists market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oncologists industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.